Wells Fargo Maintains Equal-Weight on Solventum, Raises Price Target to $95
Benzinga Newsdesk 3 hours ago
Analyst RatingsNewsPrice Target
Wells Fargo analyst Nathan Treybeck maintains Solventum (NYSE:SOLV) with a Equal-Weight and raises the price target from $89 to $95.
Wells Fargo analyst Nathan Treybeck maintains Solventum (NYSE:SOLV) with a Equal-Weight and raises the price target from $89 to $95.